No Data
CRO Services Market Report 2024, With Key Player Profiles for Medpace, ICON, IQVIA, Syneos Health, Parexel, Charles River Laboratories, Thermofisher Scientific, Pharmaron Beijing and Altasciences
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $220
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $220
Cautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target Adjustment
0.2% Earnings Growth Over 3 Years Has Not Materialized Into Gains for Charles River Laboratories International (NYSE:CRL) Shareholders Over That Period
Express News | Charles River Laboratories International Inc - Credit Agreement Reduces Revolving Commitments to $2 Billion